PUBLISHER: The Business Research Company | PRODUCT CODE: 1245036
PUBLISHER: The Business Research Company | PRODUCT CODE: 1245036
“Continous Blood Glucose Monitoring Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on continous blood glucose monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for continous blood glucose monitoring? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The continous blood glucose monitoring market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
* The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
* The impact of higher inflation in many countries and the resulting spike in interest rates.
* The continued but declining impact of COVID-19 on supply chains and consumption patterns.
Major players in the continuous blood glucose monitoring market are: Roche, Lifescan, Medtronic, Abbott, GlySens Inc., Arkray, Senseonics Holdings Inc., Glysure limited, Nemaura, Tandem Diabetes Care, Goldsite Diagonostics Inc., AgaMatrix Inc., B. Braun Melsungen, Ypsomed Holding AG, Terumo, and Orsense ltd.
The global continuous blood glucose monitoring market grew from $11.19 billion in 2022 to $12.5 billion in 2023 at a compound annual growth rate (CAGR) of 11.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The continuous blood glucose monitoring market is expected to grow to $18.83 billion in 2027 at a CAGR of 10.8%.
The continuous blood glucose monitoring market consists of sales of real-time continuous glucose monitoring, and intermittently scanned continuous glucose monitoring. Values in this market are: 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
A continuous blood glucose monitoring device enables a person to better regulate glucose levels throughout the day and to experience fewer low blood glucose situations.
North America was the largest region in the continuous blood glucose monitoring market in 2022. The regions covered in the continuous blood glucose monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The main types of components in continuous blood glucose monitoring devices are insulin pumps, sensors, transmitters, and receivers. Insulin pumps are small, computerized devices designed and programmed to deliver pre-determined doses of insulin in diabetic patients at specific intervals. These devices are used by type 1 diabetic patients, type 2 diabetic patients, gestational diabetes, and critical care patients which are used by various end-users, including hospitals, homecare diagnostics, and other end users.
The increasing prevalence of diabetes is expected to propel the growth of the continuous blood glucose monitoring market going forward. Diabetes is a health disease that occurs when the blood glucose levels fluctuate in the body. Blood glucose monitoring devices can aid in the detection of trends and patterns that give a better full picture of a diabetic's condition. For instance, according to the International Diabetes Federation, in 2020, around 463 million adults were affected by diabetes, among which 10.0% of them had type 1 diabetes, and 90.0% had type 2 diabetes. Therefore, the increasing prevalence of diabetes is driving the growth of the continuous blood glucose monitoring market.
Technological advancements have emerged as a key trend gaining popularity in the continuous blood glucose monitoring market. Major companies operating in the continuous blood glucose monitoring market are focused on developing advanced technological solutions to strengthen their position in the market. For instance, in 2020, Philips, a Netherlands-based health technology company that manufactures glucose monitoring devices launched non-invasive monitors for COPD patients based on ExpiraFlow technology. The non-invasive monitors help health care professionals to detect and screen the expiratory flow limitation and can also be used in optimal home care therapy.
In August 2020, Medtronic PLC., an Ireland-based medical device company, acquired Companion Medical for an undisclosed amount. The acquisition is intended to allow Medtronic PLC. to extend its product line and provide people with a one-of-a-kind and expansive ecosystem of support for their diabetes. Companion Medical Inc. is a US-based company that manufactures smart insulin pens which are used to monitor blood glucose.
The countries covered in the continuous blood glucose monitoring market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The continuous blood glucose monitoring market research report is one of a series of new reports from The Business Research Company that provides continuous blood glucose monitoring market statistics, including continuous blood glucose monitoring industry global market size, regional shares, competitors with a continuous blood glucose monitoring market share, detailed continuous blood glucose monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the continuous blood glucose monitoring industry. This continuous blood glucose monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.